These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 543059)

  • 1. [Heparin therapy in the nephrotic variant of glomerulonephritis].
    Peleshchuk AP; Pyrig LA; Belitskaia GA; Kasatkin OG; Ena IaM
    Urol Nefrol (Mosk); 1979; (6):29-32. PubMed ID: 543059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pentoxifylline (Trental) in the treatment of chronic glomerulonephritis].
    Shoĭkhet IN; Treĭvish VS; Novikova NN
    Ter Arkh; 1986; 58(8):71-3. PubMed ID: 3764765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of heparin in treating the nephrotic syndrome].
    Vat'ian AA
    Vrach Delo; 1973 May; 5():78-81. PubMed ID: 4757744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathological basis and therapeutic results of heparin treatment in some glomerular nephropathies with nephrotic syndrome].
    Campanacci C; Previato G
    G Clin Med; 1974 Apr; 55(4):273-95. PubMed ID: 4452438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombotic therapy in correcting hemostatic disorders in patients with chronic glomerulonephritis].
    Nazar PS; Badiuk RA
    Vrach Delo; 1990 Mar; (3):18-20. PubMed ID: 2368351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin treatment of acute and chronic glomerulonephritis].
    Gilunova NI; Tsalenchuk IaP
    Ter Arkh; 1973 May; 45(5):112-7. PubMed ID: 4768366
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with anticoagulants in glomerulonephritis (author's transl)].
    Girndt J
    Med Klin; 1979 Nov; 74(47):1767-71. PubMed ID: 522818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of the diuretic effect of heparin in chronic glomerulonephritis].
    Kutyrina IM; Nikishova TA; Lifshits NL; Aleksandrovskaia TN
    Ter Arkh; 1982; 54(7):42-6. PubMed ID: 7135221
    [No Abstract]   [Full Text] [Related]  

  • 11. [The potentials of heparin monotherapy in patients with hemorrhagic vasculitis and kidney involvement].
    Lapchyns'ka II; Pyrih LA; Bielyts'ka HO
    Lik Sprava; 1996; (5-6):130-3. PubMed ID: 9377378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin in the treatment of nephrotic syndrome].
    Paunesco-Podeanu A; Buligesco L; Beroniade V
    Therapeutique; 1970 May; 46(5):571-5. PubMed ID: 5430232
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
    Rumiantsev ISh; Kaznacheeva IG; Abdiadilova LV; Kozlov VV
    Ter Arkh; 1992; 64(6):35-9. PubMed ID: 1440334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclosporin A in the treatment of chronic glomerulonephritis with nephrotic syndrome (a review of the literature)].
    Kolesnyk MO; Lapchyns'ka II
    Lik Sprava; 1994; (3-4):34-8. PubMed ID: 7975537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effectiveness of Cyclophosphamide and Cytembena in controlled clinical trial in nephrotic syndrome and chronic glomerulonephritis].
    Sasinka M; Plenta I; Kaiserová E; Izakovic V; Pavlovic M; CYTEMBENA/*THER USE ; Slugen I; Lehký M; Stubna J
    Cesk Pediatr; 1976 Mar; 31(3):127-30. PubMed ID: 773556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with treating the nephrotic syndrome caused by glomerulonephritis].
    Ratner NA; Abugova SP; Kozdoba OA; Paleeva FM; Pliutto IA
    Ter Arkh; 1973 May; 45(5):82-90. PubMed ID: 4768380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term effect of dilazep therapy in patients with chronic glomerulonephritis and nephrotic syndrome].
    Takasaki H; Shibata M; Ito S; Kida H; Morozumi K; Iwata J
    Nihon Jinzo Gakkai Shi; 1987 Jan; 29(1):87-96. PubMed ID: 3586400
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Shindo T; Tetsutani T; Yamamoto T; Okubo H; Oka G
    Arzneimittelforschung; 1982; 32(3):301-9. PubMed ID: 7200790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.